Genetic profiling for risk reduction in human cardiovascular disease

Genes

Volumn 5, Issue 1, 2014, Pages 214-234

  Puckelwartz, Megan J ^a   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiovascular disease; Genetic profiling; Next generation sequencing; Whole genome sequencing

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONGESTIVE CARDIOMYOPATHY; COPY NUMBER VARIATION; CORONARY ARTERY DISEASE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC PROFILING; GENETIC RISK; GENETIC VARIABILITY; HERITABILITY; HUMAN; LONG QT SYNDROME; MONOGENIC DISORDER; NEXT GENERATION SEQUENCING; PHENOTYPE; REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING;

EID: 84897547365     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5010214     Document Type: Review

References (106)

1. Go, A. S.; Mozaffarian, D.; Roger, V. L.; Benjamin, E. J.; Berry, J. D.; Borden, W. B.; Bravata, D. M.; Dai, S.; Ford, E. S.; Fox, C. S.; et al. Executive summary: Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013, 127, 143-152.
2. Marenberg, M. E.; Risch, N.; Berkman, L. F.; Floderus, B.; de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 1994, 330, 1041-1046.
3. Post, W. S.; Larson, M. G.; Myers, R. H.; Galderisi, M.; Levy, D. Heritability of left ventricular mass: The Framingham Heart Study. Hypertension 1997, 30, 1025-1028.
4. Adams, T. D.; Yanowitz, F. G.; Fisher, A. G.; Ridges, J. D.; Nelson, A. G.; Hagan, A. D.; Williams, R. R.; Hunt, S. C. Heritability of cardiac size: An echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation 1985, 71, 39-44.
5. Botstein, D.; White, R. L.; Skolnick, M.; Davis, R. W. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet. 1980, 32, 314-331.
6. Jarcho, J. A.; McKenna, W.; Pare, J. A.; Solomon, S. D.; Holcombe, R. F.; Dickie, S.; Levi, T.; Donis-Keller, H.; Seidman, J. G.; Seidman, C. E. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N. Engl. J. Med. 1989, 321, 1372-1378.
7. Geisterfer-Lowrance, A. A.; Kass, S.; Tanigawa, G.; Vosberg, H. P.; McKenna, W.; Seidman, C. E.; Seidman, J. G. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation. Cell 1990, 62, 999-1006.
8. Basson, C. T.; Bachinsky, D. R.; Lin, R. C.; Levi, T.; Elkins, J. A.; Soults, J.; Grayzel, D.; Kroumpouzou, E.; Traill, T. A.; Leblanc-Straceski, J.; et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 1997, 15, 30-35.
9. Curran, M. E.; Splawski, I.; Timothy, K. W.; Vincent, G. M.; Green, E. D.; Keating, M. T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80, 795-803.
10. Dietz, H. C.; Cutting, G. R.; Pyeritz, R. E.; Maslen, C. L.; Sakai, L. Y.; Corson, G. M.; Puffenberger, E. G.; Hamosh, A.; Nanthakumar, E. J.; Curristin, S. M.; et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352, 337-339.
11. Garg, V.; Kathiriya, I. S.; Barnes, R.; Schluterman, M. K.; King, I. N.; Butler, C. A.; Rothrock, C. R.; Eapen, R. S.; Hirayama-Yamada, K.; Joo, K.; et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424, 443-447.
12. Garg, V.; Muth, A. N.; Ransom, J. F.; Schluterman, M. K.; Barnes, R.; King, I. N.; Grossfeld, P. D.; Srivastava, D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437, 270-274.
13. Schott, J. J.; Benson, D. W.; Basson, C. T.; Pease, W.; Silberbach, G. M.; Moak, J. P.; Maron, B. J.; Seidman, C. E.; Seidman, J. G. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281, 108-111.
14. Tartaglia, M.; Mehler, E. L.; Goldberg, R.; Zampino, G.; Brunner, H. G.; Kremer, H.; van der Burgt, I.; Crosby, A. H.; Ion, A.; Jeffery, S.; et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 2001, 29, 465-468.
15. Lander, E.; Kruglyak, L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat. Genet. 1995, 11, 241-247.
16. International HapMap Consortium. The International HapMap Project. Nature 2003, 426, 789-796.
17. National Human Genome Research Institute (NHGRI) Catalog of Published Genome-Wide Association Studies. Available online: http://www. genome. gov/gwasstudies/(accessed on 25 February 2014).
18. Newton-Cheh, C.; Eijgelsheim, M.; Rice, K. M.; de Bakker, P. I.; Yin, X.; Estrada, K.; Bis, J. C.; Marciante, K.; Rivadeneira, F.; Noseworthy, P. A.; et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat. Genet. 2009, 41, 399-406.
19. Villard, E.; Perret, C.; Gary, F.; Proust, C.; Dilanian, G.; Hengstenberg, C.; Ruppert, V.; Arbustini, E.; Wichter, T.; Germain, M.; et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J. 2011, 32, 1065-1076.
20. Jefferies, J. L.; Towbin, J. A. Dilated cardiomyopathy. Lancet 2010, 375, 752-762.
21. Hershberger, R. E.; Norton, N.; Morales, A.; Li, D.; Siegfried, J. D.; Gonzalez-Quintana, J. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2010, 3, 155-161.
22. Rampersaud, E.; Kinnamon, D. D.; Hamilton, K.; Khuri, S.; Hershberger, R. E.; Martin, E. R. Common susceptibility variants examined for association with dilated cardiomyopathy. Ann. Hum. Genet. 2010, 74, 110-116.
23. Tiret, L.; Mallet, C.; Poirier, O.; Nicaud, V.; Millaire, A.; Bouhour, J. B.; Roizes, G.; Desnos, M.; Dorent, R.; Schwartz, K.; et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDIGENE study. J. Am. Coll. Cardiol. 2000, 35, 29-35.
24. Takayama, S.; Xie, Z.; Reed, J. C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J. Biol. Chem. 1999, 274, 781-786.
25. Ellinor, P. T.; Sasse-Klaassen, S.; Probst, S.; Gerull, B.; Shin, J. T.; Toeppel, A.; Heuser, A.; Michely, B.; Yoerger, D. M.; Song, B. S.; et al. A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J. Am. Coll. Cardiol. 2006, 48, 106-111.
26. Norton, N.; Li, D.; Rieder, M. J.; Siegfried, J. D.; Rampersaud, E.; Zuchner, S.; Mangos, S.; Gonzalez-Quintana, J.; Wang, L.; McGee, S.; et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am. J. Hum. Genet. 2011, 88, 273-282.
27. Reich, D. E.; Lander, E. S. On the allelic spectrum of human disease. Trends Genet. 2001, 17, 502-510.
28. Wang, W. Y.; Barratt, B. J.; Clayton, D. G.; Todd, J. A. Genome-wide association studies: Theoretical and practical concerns. Nat. Rev. Genet. 2005, 6, 109-118.
29. Manolio, T. A.; Collins, F. S.; Cox, N. J.; Goldstein, D. B.; Hindorff, L. A.; Hunter, D. J.; McCarthy, M. I.; Ramos, E. M.; Cardon, L. R.; Chakravarti, A.; et al. Finding the missing heritability of complex diseases. Nature 2009, 461, 747-753.
30. McPherson, R.; Pertsemlidis, A.; Kavaslar, N.; Stewart, A.; Roberts, R.; Cox, D. R.; Hinds, D. A.; Pennacchio, L. A.; Tybjaerg-Hansen, A.; Folsom, A. R.; et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316, 1488-1491.
31. Helgadottir, A.; Thorleifsson, G.; Manolescu, A.; Gretarsdottir, S.; Blondal, T.; Jonasdottir, A.; Sigurdsson, A.; Baker, A.; Palsson, A.; Masson, G.; et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316, 1491-1493.
32. Lander, E. S. The new genomics: Global views of biology. Science 1996, 274, 536-539.
33. Pritchard, J. K.; Cox, N. J. The allelic architecture of human disease genes: Common disease-common variant. or not? Hum. Mol. Genet. 2002, 11, 2417-2423.
34. Gibson, G. Rare and common variants: Twenty arguments. Nat. Rev. Genet. 2011, 13, 135-145.
35. Manolio, T. A. Cohort studies and the genetics of complex disease. Nat. Genet. 2009, 41, 5-6.
36. Sun, J. X.; Helgason, A.; Masson, G.; Ebenesersdottir, S. S.; Li, H.; Mallick, S.; Gnerre, S.; Patterson, N.; Kong, A.; Reich, D.; et al. A direct characterization of human mutation based on microsatellites. Nat. Genet. 2012, 44, 1161-1165.
37. Marian, A. J.; Belmont, J. Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ. Res. 2011, 108, 1252-1269.
38. Ng, P. C.; Levy, S.; Huang, J.; Stockwell, T. B.; Walenz, B. P.; Li, K.; Axelrod, N.; Busam, D. A.; Strausberg, R. L.; Venter, J. C. Genetic variation in an individual human exome. PLoS Genet. 2008, 4, e1000160.
39. Tennessen, J. A.; Bigham, A. W.; O'Connor, T. D.; Fu, W.; Kenny, E. E.; Gravel, S.; McGee, S.; Do, R.; Liu, X.; Jun, G.; et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337, 64-69.
40. Johansen, C. T.; Wang, J.; Lanktree, M. B.; Cao, H.; McIntyre, A. D.; Ban, M. R.; Martins, R. A.; Kennedy, B. A.; Hassell, R. G.; Visser, M. E.; et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 2010, 42, 684-687.
41. Aulchenko, Y. S.; Ripatti, S.; Lindqvist, I.; Boomsma, D.; Heid, I. M.; Pramstaller, P. P.; Penninx, B. W.; Janssens, A. C.; Wilson, J. F.; Spector, T.; et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 2009, 41, 47-55.
42. Kathiresan, S.; Willer, C. J.; Peloso, G. M.; Demissie, S.; Musunuru, K.; Schadt, E. E.; Kaplan, L.; Bennett, D.; Li, Y.; Tanaka, T.; et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 2009, 41, 56-65.
43. Li, H.; Homer, N. A survey of sequence alignment algorithms for next-generation sequencing. Brief. Bioinforma. 2010, 11, 473-483.
44. Nielsen, R.; Paul, J. S.; Albrechtsen, A.; Song, Y. S. Genotype and SNP calling from next-generation sequencing data. Nat. Rev. Genet. 2011, 12, 443-451.
45. Abecasis, G. R.; Auton, A.; Brooks, L. D.; DePristo, M. A.; Durbin, R. M.; Handsaker, R. E.; Kang, H. M.; Marth, G. T.; McVean, G. A. An integrated map of genetic variation from 1092 human genomes. Nature 2012, 491, 56-65.
46. Jabbari, J.; Jabbari, R.; Nielsen, M. W.; Holst, A. G.; Nielsen, J. B.; Haunso, S.; Tfelt-Hansen, J.; Svendsen, J. H.; Olesen, M. S. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ. Cardiovasc. Genet. 2013, 6, 481-489.
47. Priori, S. G.; Napolitano, C.; Memmi, M.; Colombi, B.; Drago, F.; Gasparini, M.; DeSimone, L.; Coltorti, F.; Bloise, R.; Keegan, R.; et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002, 106, 69-74.
48. Golbus, J. R.; Puckelwartz, M. J.; Fahrenbach, J. P.; Dellefave-Castillo, L. M.; Wolfgeher, D.; McNally, E. M. Population-based variation in cardiomyopathy genes. Circ. Cardiovasc. Genet. 2012, 5, 391-399.
49. Risgaard, B.; Jabbari, R.; Refsgaard, L.; Holst, A. G.; Haunso, S.; Sadjadieh, A.; Winkel, B. G.; Olesen, M. S.; Tfelt-Hansen, J. High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin. Genet. 2013, 84, 489-495.
50. Kapplinger, J. D.; Landstrom, A. P.; Salisbury, B. A.; Callis, T. E.; Pollevick, G. D.; Tester, D. J.; Cox, M. G.; Bhuiyan, Z.; Bikker, H.; Wiesfeld, A. C.; et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J. Am. Coll. Cardiol. 2011, 57, 2317-2327.
51. Andreasen, C.; Refsgaard, L.; Nielsen, J. B.; Sajadieh, A.; Winkel, B. G.; Tfelt-Hansen, J.; Haunso, S.; Holst, A. G.; Svendsen, J. H.; Olesen, M. S. Mutations in genes encoding cardiac ion channels previously associated with sudden infant death syndrome (SIDS) are present with high frequency in new exome data. Can. J. Cardiol. 2013, 29, 1104-1109.
52. Petretta, M.; Pirozzi, F.; Sasso, L.; Paglia, A.; Bonaduce, D. Review and metaanalysis of the frequency of familial dilated cardiomyopathy. Am. J. Cardiol. 2011, 108, 1171-1176.
53. Meder, B.; Haas, J.; Keller, A.; Heid, C.; Just, S.; Borries, A.; Boisguerin, V.; Scharfenberger-Schmeer, M.; Stahler, P.; Beier, M.; et al. Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ. Cardiovasc. Genet. 2011, 4, 110-122.
54. Zimmerman, R. S.; Cox, S.; Lakdawala, N. K.; Cirino, A.; Mancini-DiNardo, D.; Clark, E.; Leon, A.; Duffy, E.; White, E.; Baxter, S.; et al. A novel custom resequencing array for dilated cardiomyopathy. Genet. Med. 2010, 12, 268-278.
55. Partners Healthcare. Available online: http://pcpgm. partners. org/(accessed on 25 February 2014).
56. Opitz, C. A.; Kulke, M.; Leake, M. C.; Neagoe, C.; Hinssen, H.; Hajjar, R. J.; Linke, W. A. Damped elastic recoil of the titin spring in myofibrils of human myocardium. Proc. Natl. Acad. Sci. USA 2003, 100, 12688-12693.
57. Granzier, H. L.; Irving, T. C. Passive tension in cardiac muscle: Contribution of collagen, titin, microtubules, and intermediate filaments. Biophys. J. 1995, 68, 1027-1044.
58. Horowits, R.; Kempner, E. S.; Bisher, M. E.; Podolsky, R. J. A physiological role for titin and nebulin in skeletal muscle. Nature 1986, 323, 160-164.
59. Muhle-Goll, C.; Habeck, M.; Cazorla, O.; Nilges, M.; Labeit, S.; Granzier, H. Structural and functional studies of titin's fn3 modules reveal conserved surface patterns and binding to myosin S1-A possible role in the Frank-Starling mechanism of the heart. J. Mol. Biol. 2001, 313, 431-447.
60. Cazorla, O.; Wu, Y.; Irving, T. C.; Granzier, H. Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac myocytes. Circ. Res. 2001, 88, 1028-1035.
61. Siu, B. L.; Niimura, H.; Osborne, J. A.; Fatkin, D.; MacRae, C.; Solomon, S.; Benson, D. W.; Seidman, J. G.; Seidman, C. E. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation 1999, 99, 1022-1026.
62. Gerull, B.; Atherton, J.; Geupel, A.; Sasse-Klaassen, S.; Heuser, A.; Frenneaux, M.; McNabb, M.; Granzier, H.; Labeit, S.; Thierfelder, L. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy. J. Mol. Med. 2006, 84, 478-483.
63. Gerull, B.; Gramlich, M.; Atherton, J.; McNabb, M.; Trombitas, K.; Sasse-Klaassen, S.; Seidman, J. G.; Seidman, C.; Granzier, H.; Labeit, S.; et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat. Genet. 2002, 30, 201-204.
64. Herman, D. S.; Lam, L.; Taylor, M. R.; Wang, L.; Teekakirikul, P.; Christodoulou, D.; Conner, L.; DePalma, S. R.; McDonough, B.; Sparks, E.; et al. Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 2012, 366, 619-628.
65. Ng, S. B.; Turner, E. H.; Robertson, P. D.; Flygare, S. D.; Bigham, A. W.; Lee, C.; Shaffer, T.; Wong, M.; Bhattacharjee, A.; Eichler, E. E.; et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461, 272-276.
66. Majewski, J.; Schwartzentruber, J.; Lalonde, E.; Montpetit, A.; Jabado, N. What can exome sequencing do for you? J. Med. Genet. 2011, 48, 580-589.
67. Campbell, N.; Sinagra, G.; Jones, K. L.; Slavov, D.; Gowan, K.; Merlo, M.; Carniel, E.; Fain, P. R.; Aragona, P.; di Lenarda, A.; et al. Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. PLoS One 2013, 8, e78104.
68. Wells, Q. S.; Becker, J. R.; Su, Y. R.; Mosley, J. D.; Weeke, P.; D'Aoust, L.; Ausborn, N. L.; Ramirez, A. H.; Pfotenhauer, J. P.; Naftilan, A. J.; et al. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2013, 6, 317-326.
69. Yandell, M.; Huff, C.; Hu, H.; Singleton, M.; Moore, B.; Xing, J.; Jorde, L. B.; Reese, M. G. A probabilistic disease-gene finder for personal genomes. Genome Res. 2011, 21, 1529-1542.
70. Li, D.; Morales, A.; Gonzalez-Quintana, J.; Norton, N.; Siegfried, J. D.; Hofmeyer, M.; Hershberger, R. E. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin. Transl. Sci. 2010, 3, 90-97.
71. Davydov, E. V.; Goode, D. L.; Sirota, M.; Cooper, G. M.; Sidow, A.; Batzoglou, S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 2010, 6, e1001025.
72. Adzhubei, I. A.; Schmidt, S.; Peshkin, L.; Ramensky, V. E.; Gerasimova, A.; Bork, P.; Kondrashov, A. S.; Sunyaev, S. R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7, 248-249.
73. Millat, G.; Bouvagnet, P.; Chevalier, P.; Sebbag, L.; Dulac, A.; Dauphin, C.; Jouk, P. S.; Delrue, M. A.; Thambo, J. B.; Le Metayer, P.; et al. Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur. J. Med. Genet. 2011, 54, e570-e575.
74. Lakdawala, N. K.; Dellefave, L.; Redwood, C. S.; Sparks, E.; Cirino, A. L.; Depalma, S.; Colan, S. D.; Funke, B.; Zimmerman, R. S.; Robinson, P.; et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: The distinctive natural history of sarcomeric dilated cardiomyopathy. J. Am. Coll. Cardiol. 2010, 55, 320-329.
75. Roncarati, R.; Viviani Anselmi, C.; Krawitz, P.; Lattanzi, G.; von Kodolitsch, Y.; Perrot, A.; di Pasquale, E.; Papa, L.; Portararo, P.; Columbaro, M.; et al. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur. J. Hum. Genet. 2013, 21, 1105-1111.
76. Robinson, P. N.; Kohler, S.; Bauer, S.; Seelow, D.; Horn, D.; Mundlos, S. The Human Phenotype Ontology: A tool for annotating and analyzing human hereditary disease. Am. J. Hum. Genet. 2008, 83, 610-615.
77. Perrot, A.; Hussein, S.; Ruppert, V.; Schmidt, H. H.; Wehnert, M. S.; Duong, N. T.; Posch, M. G.; Panek, A.; Dietz, R.; Kindermann, I.; et al. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res. Cardiol. 2009, 104, 90-99.
78. Theis, J. L.; Sharpe, K. M.; Matsumoto, M. E.; Chai, H. S.; Nair, A. A.; Theis, J. D.; de Andrade, M.; Wieben, E. D.; Michels, V. V.; Olson, T. M. Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2011, 4, 585-594.
79. Vermeulen, M.; Eberl, H. C.; Matarese, F.; Marks, H.; Denissov, S.; Butter, F.; Lee, K. K.; Olsen, J. V.; Hyman, A. A.; Stunnenberg, H. G.; et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142, 967-980.
80. Alkan, C.; Coe, B. P.; Eichler, E. E. Genome structural variation discovery and genotyping. Nat. Rev. Genet. 2011, 12, 363-376.
81. Iafrate, A. J.; Feuk, L.; Rivera, M. N.; Listewnik, M. L.; Donahoe, P. K.; Qi, Y.; Scherer, S. W.; Lee, C. Detection of large-scale variation in the human genome. Nat. Genet. 2004, 36, 949-951.
82. Tuzun, E.; Sharp, A. J.; Bailey, J. A.; Kaul, R.; Morrison, V. A.; Pertz, L. M.; Haugen, E.; Hayden, H.; Albertson, D.; Pinkel, D.; et al. Fine-scale structural variation of the human genome. Nat. Genet. 2005, 37, 727-732.
83. Kidd, J. M.; Cooper, G. M.; Donahue, W. F.; Hayden, H. S.; Sampas, N.; Graves, T.; Hansen, N.; Teague, B.; Alkan, C.; Antonacci, F.; et al. Mapping and sequencing of structural variation from eight human genomes. Nature 2008, 453, 56-64.
84. Krumm, N.; Sudmant, P. H.; Ko, A.; O'Roak, B. J.; Malig, M.; Coe, B. P.; Quinlan, A. R.; Nickerson, D. A.; Eichler, E. E. Copy number variation detection and genotyping from exome sequence data. Genome Res. 2012, 22, 1525-1532.
85. Magi, A.; Tattini, L.; Cifola, I.; D'Aurizio, R.; Benelli, M.; Mangano, E.; Battaglia, C.; Bonora, E.; Kurg, A.; Seri, M.; et al. EXCAVATOR: Detecting copy number variants from whole-exome sequencing data. Genome Biol. 2013, 14, R120.
86. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436, 214-220.
87. Thum, T.; Galuppo, P.; Wolf, C.; Fiedler, J.; Kneitz, S.; van Laake, L. W.; Doevendans, P. A.; Mummery, C. L.; Borlak, J.; Haverich, A.; et al. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 2007, 116, 258-267.
88. Zhao, Y.; Ransom, J. F.; Li, A.; Vedantham, V.; von Drehle, M.; Muth, A. N.; Tsuchihashi, T.; McManus, M. T.; Schwartz, R. J.; Srivastava, D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129, 303-317.
89. Van Rooij, E.; Sutherland, L. B.; Qi, X.; Richardson, J. A.; Hill, J.; Olson, E. N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316, 575-579.
90. Callis, T. E.; Pandya, K.; Seok, H. Y.; Tang, R. H.; Tatsuguchi, M.; Huang, Z. P.; Chen, J. F.; Deng, Z.; Gunn, B.; Shumate, J.; et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 2009, 119, 2772-2786.
91. Montgomery, R. L.; Hullinger, T. G.; Semus, H. M.; Dickinson, B. A.; Seto, A. G.; Lynch, J. M.; Stack, C.; Latimer, P. A.; Olson, E. N.; van Rooij, E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124, 1537-1547.
92. Rao, P. K.; Toyama, Y.; Chiang, H. R.; Gupta, S.; Bauer, M.; Medvid, R.; Reinhardt, F.; Liao, R.; Krieger, M.; Jaenisch, R.; et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 2009, 105, 585-594.
93. Bernstein, B. E.; Birney, E.; Dunham, I.; Green, E. D.; Gunter, C.; Snyder, M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57-74.
94. Hindorff, L. A.; Sethupathy, P.; Junkins, H. A.; Ramos, E. M.; Mehta, J. P.; Collins, F. S.; Manolio, T. A. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 2009, 106, 9362-9367.
95. Wang, K.; Kim, C.; Bradfield, J.; Guo, Y.; Toskala, E.; Otieno, F. G.; Hou, C.; Thomas, K.; Cardinale, C.; Lyon, G. J.; et al. Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement. Genome Med. 2013, 5, 67.
96. Wang, K.; Li, M.; Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38, e164.
97. Benjamini, Y.; Speed, T. P. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res. 2012, 40, e72.
98. Sirmaci, A.; Edwards, Y. J.; Akay, H.; Tekin, M. Challenges in whole exome sequencing: An example from hereditary deafness. PLoS One 2012, 7, e32000.
99. Siepel, A.; Bejerano, G.; Pedersen, J. S.; Hinrichs, A. S.; Hou, M.; Rosenbloom, K.; Clawson, H.; Spieth, J.; Hillier, L. W.; Richards, S.; et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005, 15, 1034-1050.
100. Ng, P. C.; Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31, 3812-3814.
101. Cooper, G. M.; Stone, E. A.; Asimenos, G.; Green, E. D.; Batzoglou, S.; Sidow, A. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005, 15, 901-913.
102. Thomas, P. D.; Kejariwal, A.; Campbell, M. J.; Mi, H.; Diemer, K.; Guo, N.; Ladunga, I.; Ulitsky-Lazareva, B.; Muruganujan, A.; Rabkin, S.; et al. PANTHER: A browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 2003, 31, 334-341.
103. Ashkenazy, H.; Erez, E.; Martz, E.; Pupko, T.; Ben-Tal, N. ConSurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010, 38, W529-W533.
104. Yeo, G.; Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004, 11, 377-394.
105. Bookman, E. B.; Langehorne, A. A.; Eckfeldt, J. H.; Glass, K. C.; Jarvik, G. P.; Klag, M.; Koski, G.; Motulsky, A.; Wilfond, B.; Manolio, T. A.; et al. Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group. Am. J. Med. Genet. A 2006, 140, 1033-1040.
106. Green, R. C.; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; McGuire, A. L.; Nussbaum, R. L.; O'Daniel, J. M.; Ormond, K. E.; et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013, 15, 565-574.